Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

The Neuropsychiatric Inventory

1994 • 7,026 citations

Memantine in Moderate-to-Severe Alzheimer's Disease

2003 • 1,889 citations

The Neuropsychiatric Inventory

1997 • 1,874 citations

Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia

2005 • 1,591 citations

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

2004 • 1,350 citations

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

2006 • 1,125 citations

The spectrum of behavioral changes in Alzheimer's disease

1996 • 1,090 citations

Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

2005 • 947 citations

Patient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia

2002 • 873 citations

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data

1999 • 841 citations

Memantine in severe dementia: results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine)

1999 • 532 citations

The Course of Psychopathologic Features in Mild to Moderate Alzheimer Disease

1997 • 344 citations

Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial

2006 • 291 citations

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

2008 • 269 citations

The incremental direct costs associated with behavioral symptoms in AD

2002 • 245 citations

NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation

2006 • 236 citations

Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease

2001 • 222 citations

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment

2006 • 220 citations

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

2005 • 199 citations

A 24-week Randomized, Controlled Trial of Memantine in Patients With Moderate-to-severe Alzheimer Disease

2007 • 168 citations

Alzheimer's disease with delusions and hallucinations

1991 • 155 citations

Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis

2000 • 154 citations

Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

2004 • 144 citations

A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease

2000 • 136 citations

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

2007 • 136 citations

Psychopathological Features in Alzheimer's Disease: Course and Relationship with Cognitive Status

2003 • 122 citations

Agitation in Alzheimer’s Disease Is a Manifestation of Frontal Lobe Dysfunction

2003 • 121 citations

Involvement of in the abnormal hyperphosphorylation of tau and its reversal by Memantine

2006 • 117 citations

Healthy Brain Aging

2002 • 27 citations

O3–05–07: Reduction of hyperphosphorylated–tau during memantine treatment of Alzheimer′s disease

2006 • 5 citations